Universal (UVV) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
9 Feb, 2026Executive summary
Delivered solid performance for the nine months and third quarter ended December 31, 2025, with strong tobacco operations and continued revenue growth in the ingredients business despite market headwinds.
Revenue decreased 8% for the quarter and 2% for the nine months, mainly due to lower tobacco sales volumes and prices, and product mix in ingredients operations.
Tobacco operations remained the primary profit driver, with segment operating income of $185 million for the nine months, while ingredients operations saw revenue growth but a sharp drop in operating income due to higher fixed costs and market softness.
Significant steps taken to strengthen the company, including refinancing and upsizing the credit facility and appointing a new CFO.
Published the FY2025 Sustainability Report, highlighting a significant increase in renewable electricity use and ongoing supply chain and farmer engagement initiatives.
Financial highlights
Nine months ended December 31, 2025: consolidated revenue $2.21B (down from $2.25B), operating income $183M (down from $190M), net income $75.9M (down from $85.7M) year-over-year.
Third quarter revenue $861M (down from $937.2M), operating income $82M (down from $104.1M), net income $33.2M (down from $59.6M) compared to the same quarter last year.
Tobacco segment Q3 revenue $780M (down from $853.9M), operating income $84M (down from $102.6M); Ingredients segment Q3 revenue $81M (down from $83.3M), operating loss $0.1M (down from $3.7M income).
Diluted EPS was $1.32 for the quarter and $3.02 for the nine months, both down from the prior year.
Gross margin declined to 18.5% for the quarter (down 220 bps) and 18.7% for the nine months (down 60 bps).
Outlook and guidance
Management expects to navigate evolving tobacco market oversupply with sourcing expertise and local presence.
Focus remains on scaling the ingredients business to absorb fixed costs and drive growth, with optimism for improved pricing as higher-cost inventory is worked through.
Tax rate expected to increase to 28–32% due to new country-specific taxes and earnings mix.
Capital expenditures projected at $45–$55 million over the next twelve months for maintenance and growth investments.
Latest events from Universal
- Q1 FY2025 revenue up 15% and operating income up 56%, with strong demand across segments.UVV
Q1 20252 Feb 2026 - Strategy centers on tobacco leadership, scaling ingredients, and sustainable, profitable growth.UVV
28th Annual ICR Conference 202613 Jan 2026 - Shareholders will vote on directors, executive pay, and auditor ratification amid strong results and ESG progress.UVV
Proxy Filing1 Dec 2025 - Proxy covers director elections, say-on-pay, auditor ratification, and strong ESG focus.UVV
Proxy Filing1 Dec 2025 - Annual meeting to elect directors, approve pay, and ratify auditor, with updated proxy card.UVV
Proxy Filing1 Dec 2025 - Revenue up 7% to $2.95B, operating income up 5%, with strong segment growth and improved liquidity.UVV
Q4 202526 Nov 2025 - Operating income nearly doubled on strong tobacco margins, despite higher costs and tariff risks.UVV
Q1 202623 Nov 2025 - Revenue and net income increased, offsetting margin pressures and supporting growth initiatives.UVV
Q2 202613 Nov 2025 - Digital-first growth, strong Asia expansion, and premium wellness products drive performance.UVV
Investor Presentation27 Jun 2025